Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (181-190 of 222) with videos related to

Pageof 23
Sort By:
BMC Cancer|December 23, 2008
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancerFlorian R Fritzsche, Wilko Weichert, Annika Röske, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 14, 2004
Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancerLisa Kurlender, George M Yousef, Nader Memari, et al.
Anti-Cancer Drugs|August 13, 2005
Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in ratsClaudia Abramjuk, Klaus Jung, Hans-Willi Krell, et al.
European Urology|February 27, 2007
Serial markers of bone turnover in men with metastatic prostate cancer treated with zoledronic Acid for detection of bone metastases progressionMichael Lein, Manfred Wirth, Kurt Miller, et al.
International Journal of Oncology|July 20, 2011
miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progressionAnnika Fendler, Monika Jung, Carsten Stephan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 4, 2005
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancerGeorge M Yousef, Nicole M A White, Lisa Kurlender, et al.
The Journal of Urology|December 11, 2003
Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancerCarsten Stephan, George M Yousef, Andreas Scorilas, et al.
Analytical Biochemistry|July 12, 2011
Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastasesZofia Wotschofsky, Helmuth-Alexander Meyer, Monika Jung, et al.
International Journal of Cancer|May 7, 2002
An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigationCarsten Stephan, Klaus Jung, Henning Cammann, et al.
The American Journal of Pathology|July 13, 2014
KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomyJohannes Stein, Michael Majores, Magdalena Rohde, et al.
Pageof 23

Showing results (181-190 of 222) with videos related to

Sort By:
Pageof 23
BMC Cancer|December 23, 2008
Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancerFlorian R Fritzsche, Wilko Weichert, Annika Röske, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 14, 2004
Differential expression of a human kallikrein 5 (KLK5) splice variant in ovarian and prostate cancerLisa Kurlender, George M Yousef, Nader Memari, et al.
Anti-Cancer Drugs|August 13, 2005
Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in ratsClaudia Abramjuk, Klaus Jung, Hans-Willi Krell, et al.
European Urology|February 27, 2007
Serial markers of bone turnover in men with metastatic prostate cancer treated with zoledronic Acid for detection of bone metastases progressionMichael Lein, Manfred Wirth, Kurt Miller, et al.
International Journal of Oncology|July 20, 2011
miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progressionAnnika Fendler, Monika Jung, Carsten Stephan, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 4, 2005
The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancerGeorge M Yousef, Nicole M A White, Lisa Kurlender, et al.
The Journal of Urology|December 11, 2003
Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancerCarsten Stephan, George M Yousef, Andreas Scorilas, et al.
Analytical Biochemistry|July 12, 2011
Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastasesZofia Wotschofsky, Helmuth-Alexander Meyer, Monika Jung, et al.
International Journal of Cancer|May 7, 2002
An artificial neural network considerably improves the diagnostic power of percent free prostate-specific antigen in prostate cancer diagnosis: results of a 5-year investigationCarsten Stephan, Klaus Jung, Henning Cammann, et al.
The American Journal of Pathology|July 13, 2014
KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomyJohannes Stein, Michael Majores, Magdalena Rohde, et al.
Pageof 23